[go: up one dir, main page]

ZA200603236B - Methods for the preparation of {2-[8,9-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof - Google Patents

Methods for the preparation of {2-[8,9-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof

Info

Publication number
ZA200603236B
ZA200603236B ZA200603236A ZA200603236A ZA200603236B ZA 200603236 B ZA200603236 B ZA 200603236B ZA 200603236 A ZA200603236 A ZA 200603236A ZA 200603236 A ZA200603236 A ZA 200603236A ZA 200603236 B ZA200603236 B ZA 200603236B
Authority
ZA
South Africa
Prior art keywords
diaza
dioxo
bicyclo
esters
ethyl
Prior art date
Application number
ZA200603236A
Other languages
English (en)
Inventor
Bogdan K Wilk
Liu Weiguo
Vid Galina
Shi Xinxu
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ZA200603236B publication Critical patent/ZA200603236B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200603236A 2003-10-22 2006-04-21 Methods for the preparation of {2-[8,9-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof ZA200603236B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51361103P 2003-10-22 2003-10-22

Publications (1)

Publication Number Publication Date
ZA200603236B true ZA200603236B (en) 2009-09-30

Family

ID=34520119

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200603236A ZA200603236B (en) 2003-10-22 2006-04-21 Methods for the preparation of {2-[8,9-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof

Country Status (17)

Country Link
US (2) US7345032B2 (xx)
EP (1) EP1675863A2 (xx)
JP (1) JP2007509857A (xx)
KR (1) KR20060094967A (xx)
CN (1) CN1871246A (xx)
AR (1) AR046130A1 (xx)
AU (1) AU2004284066A1 (xx)
BR (1) BRPI0415857A (xx)
CA (1) CA2543008A1 (xx)
CO (1) CO5690562A2 (xx)
GT (1) GT200400213A (xx)
MX (1) MXPA06004397A (xx)
PA (1) PA8615401A1 (xx)
PE (1) PE20050908A1 (xx)
TW (1) TW200514775A (xx)
WO (1) WO2005040176A2 (xx)
ZA (1) ZA200603236B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1622625A1 (en) * 2003-04-09 2006-02-08 Wyeth Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo [5.2.o] non-1 (7)-en-2-yl )alkyl] phosphonic acid and derivatives and methods of use thereof
BRPI1009900A2 (pt) 2009-03-19 2016-03-15 Wyeth Llc métodos para a preparação de ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)etil]fosfônico e seus precursores
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
CN110996948A (zh) 2017-06-12 2020-04-10 格莱泰施有限责任公司 用nmda拮抗剂和d2/5ht2a或选择性5ht2a拮抗剂治疗抑郁症

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518660A1 (de) 1965-07-09 1969-08-14 Huels Chemische Werke Ag Verfahren zur Herstellung aminosubstituierter Dioxocyclobutene
DE2428691A1 (de) * 1974-06-14 1976-01-08 Merck Patent Gmbh Hexahydro-diazepino-indolderivate und verfahren zu ihrer herstellung
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids
US5212291A (en) * 1986-10-23 1993-05-18 American Cyanamid Company Anthracycline derivatives as solubilized pro-drugs
JPH02184673A (ja) * 1989-01-11 1990-07-19 Yoshitomi Pharmaceut Ind Ltd スルホンアミド化合物
US5236695A (en) * 1989-11-27 1993-08-17 Concat, Ltd. MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
ATE120753T1 (de) * 1990-08-21 1995-04-15 Upjohn Co Bisphosphonsäurederivate als antiarthritische mittel.
US5168103A (en) * 1991-01-22 1992-12-01 American Home Products Corporation [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl) amino]alkyl]-acid derivatives
US5124319A (en) * 1991-10-11 1992-06-23 American Home Products Corporation Benzimidazole phosphono-amino acids
US5708152A (en) * 1992-03-27 1998-01-13 Ciba Specialty Chemicals Corporation N-substituted chitosan derivatives in a process for their preparation
DK124393D0 (da) 1993-11-03 1993-11-03 Lundbeck & Co As H Compounds
US5583123A (en) * 1994-12-22 1996-12-10 Ciba-Geigy Corporation Certain tetrazole derivatives
TW427904B (en) 1995-12-07 2001-04-01 American Home Prod Neuroprotective agents
UA52698C2 (uk) 1996-10-04 2003-01-15 Х. Луннбек А/С Похідні (3-алкоксіізоксазол-4-іл)заміщеної 2-амінокарбонової кислоти та їх сірковмісні аналоги, фармацевтична композиція на їх основі
AU746119B2 (en) 1997-08-01 2002-04-18 Wyeth Process for the preparation of (2-((8,9)- dioxo-2,6-diazabicyclo (5.2.0)-non-1(7)-en-2-yl)-ethyl) phosphonic acid
US5990307A (en) * 1997-08-01 1999-11-23 American Home Products Corporation Process for the preparation of [2-((8.9)-Dioxo-2,6-Diazabicyclo [5.2.0]-Non-1(7)-en-2yl) Ethyl]Phosphonic acid
US6541669B1 (en) 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists
UA78529C2 (en) * 2001-10-10 2007-04-10 Wyeth Corp Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain
US20040082543A1 (en) * 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
DK1611144T3 (da) * 2003-04-09 2010-11-22 Wyeth Llc Derivater af 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl-phosphonsyre og deres avendelse som n-methyl-D-aspartat (NMDA)-receptor-antagonister
EP1622625A1 (en) 2003-04-09 2006-02-08 Wyeth Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo [5.2.o] non-1 (7)-en-2-yl )alkyl] phosphonic acid and derivatives and methods of use thereof
US20050142192A1 (en) 2003-10-15 2005-06-30 Wyeth Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives
KR20070100233A (ko) 2004-10-08 2007-10-10 와이어쓰 [2-(8,9-디옥소-2,6-디아자바이사이클로[5.2.0]논-1(7)-엔-2-일)알킬]포스폰산의 유도체 및 이의 제조 방법

Also Published As

Publication number Publication date
JP2007509857A (ja) 2007-04-19
GT200400213A (es) 2007-09-05
PE20050908A1 (es) 2005-12-02
MXPA06004397A (es) 2006-06-14
AR046130A1 (es) 2005-11-23
KR20060094967A (ko) 2006-08-30
BRPI0415857A (pt) 2007-01-09
CA2543008A1 (en) 2005-05-06
WO2005040176A2 (en) 2005-05-06
TW200514775A (en) 2005-05-01
PA8615401A1 (es) 2005-11-25
WO2005040176A3 (en) 2005-12-01
CO5690562A2 (es) 2006-10-31
US20050090470A1 (en) 2005-04-28
US7345032B2 (en) 2008-03-18
US20080114165A1 (en) 2008-05-15
CN1871246A (zh) 2006-11-29
EP1675863A2 (en) 2006-07-05
AU2004284066A1 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
TWI349674B (en) Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of use thereof
AU2003280373A1 (en) Method of administering bisphosphonates
IL173035A0 (en) 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (p13) for the treatment of inflammatory airway diseases
AU2002362774A1 (en) Cyclosporin analogs for the treatment of lung diseases
AU2003253175A1 (en) Process for the preparation of flavor or fragrance microcapsules
PT2272824T (pt) Processo para a produção de 2,4¿-metilenodifenildiisocianato muito puro
ZA200603236B (en) Methods for the preparation of {2-[8,9-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof
PL373723A1 (en) Process for the preparation of 1,2-benzisoxazole-3-acetic acid
AU2001242376A1 (en) Process for the preparation of 2-hydroxy-4-methylthiobutyric acid esters
GB2383795B (en) Preparation of triethyl phosphate
AU2003275267A1 (en) Method for the preparation of 2-halo-2'-deoxyadenosine compounds from 2'-deoxyguanosine
ITMI20030778A1 (it) Procedimento per la preparazione enzimatica dell'aroma di vaniglia.
AU2003265845A1 (en) METHODS FOR THE PREPARATION OF Beta-AMINO ACIDS
WO2005023216A3 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulans äure
ZA200603035B (en) Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0.] non-1 (7)-en-2-yl)alkyl]phosphonic acid and derivatives
IL162770A0 (en) Process for the preparation methylsteroids of 7
IL144063A0 (en) Process for the preparation of 1,1-cyclohexanediacetic acid
WO2003011221A3 (en) PREPARATION AND USE OF α-KETO PHOSPHONATES
AU2002347652A1 (en) Process for the preparation of an enantiomerically enriched a-amino acid
AU2001268461A1 (en) Uncoupling proteins as targets for the treatment of heart failure
AU2003227524A1 (en) Use of bisphosphonic acid derivatives for the treatment of calcium phrophosphated deposition disease and dental treatment
AU2001237790A1 (en) Method for the preparation of (s)-2-acetylthio-3-phenylpropionic acid
AU2001276410A1 (en) Medicament for oral application, containing aminopropyl phosphonic acid esters as an active ingredient
IL172377A0 (en) 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders
AU2002316940A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof